https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
115
 
downloads
26
CITE
How to cite this poster:
Wattmo C, Minthon L and Wallin Ã…K Three-Year outcome of rivastigmine treatment in Alzheimer's Disease in a routine clinical setting. F1000Posters 2015, 6:359 (poster)

Three-Year outcome of rivastigmine treatment in Alzheimer's Disease in a routine clinical setting

Carina Wattmo1, Carina Wattmo2, Lennart Minthon, Åsa K. Wallin
Published 21 May 2015
Author Affiliations
  • Metrics
  • 115 Views
  • 26 Downloads
Browse by related subjects
Published 21 May 2015

Three-Year outcome of rivastigmine treatment in Alzheimer's Disease in a routine clinical setting

[version 1; not peer reviewed]

Carina Wattmo1, Carina Wattmo2, Lennart Minthon, Åsa K. Wallin
Author Affiliations
1 Memory Clinic, Skåne University Hospital, Sweden
2 Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sweden
Presented at
11th International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2013)
Abstract
Competing Interests

No competing interests were disclosed

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.